Skip to main content
. 2022 Nov 7;13:1053330. doi: 10.3389/fmicb.2022.1053330

Figure 4.

Figure 4

Effect of exogenous D-ribose on SCH-R and clinical isolates of drug-resistant Salmonella. (A) Percent survival of SCH-R in the presence of 1 MIC gentamicin by D-ribose dose. (B) Percent survival of SCH2021 in the presence of 1 MIC gentamicin by D-ribose dose. (C) Percent survival of SCH-R in the presence of 24 mM D-ribose by gentamicin dose. (D–G) Percent survival of clinical isolates SCH2021 (D), SR-1 (E), SR-6 (F), and SR-7 (G) in the presence of different aminoglycosides (1MIC) by D-ribose dose. Results are displayed as the mean ± SEM and three biological repeats are carried out. Significant differences are identified (*p < 0.05 and **p < 0.01).